Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Topic Review

Aphasia and Thalamotomy: Important Issues

Bruce B.B.a · Foote K.D.a,b · Rosenbek J.a,c · Sapienza C.c · Romrell J.a · Crucian G.a · Okun M.S.a,b

Author affiliations

Departments of aNeurology, bNeurosurgery, cSpeech and Communicative Disorders, McKnight Brain Institute, Movement Disorders Center, University of Florida, Gainesville, Fla., USA

Related Articles for ""

Stereotact Funct Neurosurg 2004;82:186–190

Do you have an account?

Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information












By signing up for MyKarger you will automatically participate in our year-End raffle.
If you Then Do Not wish To participate, please uncheck the following box.

Yes, I wish To participate In the year-End raffle And Get the chance To win some Of our most interesting books, And other attractive prizes.


I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Topic Review

Published online: December 10, 2004
Issue release date: December 2004

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 0

ISSN: 1011-6125 (Print)
eISSN: 1423-0372 (Online)

For additional information: https://www.karger.com/SFN

Abstract

Patients may present with classical symptoms suggesting aphasia following thalamotomy (repetition, comprehension, fluency and naming abnormalities). They may also present with ‘freezing of speech’, and this symptom should not be considered as a speech disorder or a symptom of Parkinson’s disease progression, without careful testing to rule out language deficits, particularly dysfluency. There are important issues related to all language complications of thalamotomy, including (1) the time course of problems following surgery, (2) the impact of preexistingspeech problems, (3) the importance of the size and location of lesions, (4) the potential circuits important in the pathogenesis of a thalamic language disturbance and (5) whether laterality makes a difference (left- versus right-sided thalamic lesions). As more centers switch from thalamotomy to deep brain stimulation, the issues regarding aphasia will need to be addressed.

© 2004 S. Karger AG, Basel


References

  1. Bell DS: Speech functions of the thalamus inferred from the effects of thalamotomy. Brain 1968;91:619–638.
  2. Crosson B, Parker JC, Kim AK, Warren RL, Kepes JJ, Tully R: A case of thalamic aphasia with postmortem verification. Brain Lang 1986;29:301–314.
  3. Critchley EM: Speech disorders of parkinsonism: A review. J Neurol Neurosurg Psychiatry 1981;44:751–758.
  4. Frank F, Fabrizi AP, Gaist G, Weigel K, Mundinger F: Stereotactic mesencephalotomy versus multiple thalamotomies in the treatment of chronic cancer pain syndromes. Appl Neurophysiol 1987;50:314–318.
  5. Rosenbek J: Stuttering secondary to nervous system damage; in Curlee RF, Perkins WH (eds): Nature and Treatment of Stuttering: New Directions. San Diego, College-Hill Press, 1984, pp 31–48.
  6. Rosenbek J, Messert B, Collins M, Wertz RT: Stuttering following brain damage. Brain Lang 1978;6:82–96.
  7. Jonas S: The thalamus and aphasia, including transcortical aphasia: A review. J Commun Dis 1982;15:31–41.
  8. Loher TJ, Gutbrod K, Fravi NL, Pohle T, Burgunder JM, Krauss JK: Thalamic stimulation for tremor. Subtle changes in episodic memory are related to stimulation per se and not to a microthalamotomy effect. J Neurol 2003;250:707–713.
  9. Botez MI, Barbeau A: Role of subcortical structures, and particularly of the thalamus, in the mechanisms of speech and language. A review. Int J Neurol 1971;8:300–320.
  10. Lhermitte F: Language disorders and their relationship to thalamic lesions. Adv Neurol 1984;42:99–113.
  11. Penfield W, Roberts L: Speech and Brain Mechanisms. Princeton, Princeton University Press, 1959.
  12. Lazzarino LG, Nicolai A, Valassi F, Biasizzo E: Language disturbances from mesencephalo-thalamic infarcts. Identification of thalamic nuclei by CT-reconstructions. Neuroradiology 1991;33:300–304.
  13. Crosson B: Subcortical functions in language: A working model. Brain Lang 1985;25:257–292.
  14. Canter GJ: Observations on neurogenic stuttering: A contribution to differential diagnosis. Br J Disord Commun 1971;6:139–143.
  15. Helm NA, Butler RB, Benson DF: Acquired stuttering. Neurology 1978;28:1159–1165.
  16. Crosson B: Subcortical mechanisms in language: Lexical-semantic mechanisms and the thalamus. Brain Cogn 1999;40:414–438.
  17. Nadeau SE, Crosson B: Subcortical aphasia. Brain Lang 1997;58:355–402; discussion 418–423.
  18. Hermann K, Turner JW, Gillingham FJ, Gaze RM: The effects of destructive lesions and stimulation of the basal ganglia on speech mechanisms. Confin Neurol 1966;27:197–207.
  19. Okun MS, Stover NP, Subramanian T, et al: Complications of gamma knife surgery for Parkinson disease. Arch Neurol 2001;58:1995–2002.
  20. Duma CM, Jacques D, Kopyov OV: The treatment of movement disorders using gamma knife stereotactic radiosurgery. Neurosurg Clin N Am 1999;10:379–389.
  21. Duma CM, Jacques DB, Kopyov OV, Mark RJ, Copcutt B, Farokhi HK: Gamma knife radiosurgery for thalamotomy in parkinsonian tremor: A five-year experience. J Neurosurg 1998;88:1044–1049.
  22. Ohye C, Shibazaki T, Hirato M, Inoue H, Andou Y: Gamma thalamotomy for parkinsonian and other kinds of tremor. Stereotact Funct Neurosurg 1996;66:333–342.
  23. Friedman JH, Epstein M, Sanes JN, et al: Gamma knife pallidotomy in advanced Parkinson’s disease. Ann Neurol 1996;39:535–538.
  24. Okun MS, Vitek JL: Lesion therapy for Parkinson’s disease and other movement disorders: Update and controversies. Mov Disord 2004;19:375–389.
  25. Hirai T, Miyazaki M, Nakajima H, Shibazaki T, Ohye C: The correlation between tremor characteristics and the predicted volume of effective lesions in stereotaxic nucleus ventralis intermedius thalamotomy. Brain 1983;106(pt 4):1001–1018.
  26. Bakay RA: Thalamic deep brain stimulation for essential tremor: Relation of lead location to outcome. Neurosurgery 2004;55:266–267.
  27. Nagaseki Y, Shibazaki T, Hirai T, et al: Long-term follow-up study of selective VIM-thalamotomy (in Japanese). No To Shinkei 1985;37:545–554.
  28. Ojemann GA: Language and the thalamus: Object naming and recall during and after thalamic stimulation. Brain Lang 1975;2:101–120.
  29. Ojemann GA, Ward AA Jr: Speech representation in ventrolateral thalamus. Brain 1971;94:669–680.
  30. Beck E, Bignami A: Some neuro-anatomical observations in cases with stereotactic lesions for the relief of parkinsonism. Brain 1968;91:589–618.
  31. Darley FL, Brown JR, Swenson WM: Language changes after neurosurgery for Parkinsonism. Brain Lang 1975;2:65–69.
  32. Ojemann GA, Van Buren JM: Respiratory, heart rate, and GSR responses from human diencephalon. Arch Neurol 1967;16:74–88.
  33. Kocher U, Siegfried J, Perret E: Verbal and nonverbal learning ability of Parkinson patients before and after unilateral ventrolateral thalamotomy. Appl Neurophysiol 1982;45:311–316.
  34. Riklan M, Cooper IS: Psychometric studies of verbal functions following thalamic lesions in humans. Brain Lang 1975;2:45–64.
  35. Kelly PJ, Gillingham FJ: The long-term results of stereotaxic surgery and L-dopa therapy in patients with Parkinson’s disease. A 10-year follow-up study. J Neurosurg 1980;53:332–337.

Article / Publication Details

First-Page Preview
Abstract of Topic Review

Published online: December 10, 2004
Issue release date: December 2004

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 0

ISSN: 1011-6125 (Print)
eISSN: 1423-0372 (Online)

For additional information: https://www.karger.com/SFN


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.